Navigation Links
Cleveland Clinic research finds no benefit over placebo in ASSURE trial
Date:9/8/2013

Monday, Sept. 3, 2013, Cleveland: Patients with coronary artery disease and low levels of "good cholesterol or high-density lipoprotein (HDL) who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).

The drug, RVX-208, induces the production of apolipoprotein A1 (apoA1), a major protein in HDL. Prior research has shown that higher levels of HDL are associated with improved coronary health, so the ASSURE trial was designed to test whether increased production of apoA1 with the drug RVX-208 would raise HDL levels and slow the progression of coronary atherosclerosis, or plaque build-up in the coronary arteries.

The results of the ASSURE (ApoA1 Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation) trial were presented at the European Society of Cardiology Congress 2013. ASSURE was a prospective, randomized, multicenter, double-blind clinical trial.

A team of researchers led by Stephen J. Nicholls, M.D., Ph.D., senior consultant to Cleveland Clinic's C5Research and Professor of Cardiology and Deputy Director at the South Australian Health & Medical Research Institute (SAHMRI) in Adelaide, Australia, used intravascular ultrasonography (IVUS) to assess the degree of coronary disease in study subjects at baseline and after 26 weeks on oral RVX-208 or placebo. IVUS is a medical imaging technology in which a small ultrasound probe is inserted via a catheter into an artery, allowing physicians to examine the inside of arteries via sonogram. The researchers also took baseline and 26-week measurements of apoA1 and HDL.

The primary endpoint the change in percent atheroma volume (PAV), or the amount of artery volume taken up by disease was not met. The PAV decreased by 0.4 perc
'/>"/>

Contact: Wyatt DuBois
duboisw@ccf.org
216-445-9946
Cleveland Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cleveland Clinic research finds blood pressure drug tends to slow coronary disease
2. Cleveland Clinic researcher finds genetic mutation in castration-resistant prostate cancer
3. CE Lectures on the Dental Treatment of Snoring and Sleep Apnea Include Rochester, Cleveland and Ft. Lauderdale, as Sleep Seminar Destinations
4. Cleveland Indians vs. Detroit Tigers Tickets: Cheap Concert Tickets Slashes Prices on All Indians vs. Tigers Tickets for August 5th - August 8th Series Progressive Field
5. National Transitions of Care Coalition to Host Regional Summit in Cleveland
6. Maroon 5 & Kelly Clarkson Ticket Prices Slashed for Concerts in Long Island, Holmdel, Cincinnati, Pittsburgh, Camden/Philly, Boston/Mansfield, Chicago, Cleveland & Detroi
7. Explorys Proud to Sponsor Cleveland GiveCamp
8. NEONI Participates in Healthcare Career Event at Cleveland Convention Center Grand Opening
9. Cleveland Clinic Laboratories to provide testing and diagnostic services to ACL Laboratories
10. Book of Mormon Tickets: Prices Slashed on Book of Mormon Tickets in New York, Chicago, Cleveland, Buffalo, Washington DC, Minneapolis, Houston and San Antonio
11. Cancer Survivor David Emerson Awarded Volkswagen Cup at Cleveland Marathon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... By Dennis Thompson ... -- Very sick children with complex chronic illnesses can receive ... a "medical home," with easy access to a team of ... were less likely to become seriously ill and need either ... received treatment at an enhanced medical home clinic at the ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... December 25, 2014 Residents at ... Community, recently showed their generous spirit by providing ... Catawba County Parenting Network- Grandparents Raising Grandchildren program. ... gathered around the largest Christmas tree on the ... purchased by residents of the Abernethy Village Association ...
Breaking Medicine News(10 mins):Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Retirement Community Residents Make Impact During Holiday Season 2
... Few things are as important to,remember than the ... overly scheduled world collides with a son or daughter,s ... a visit to the,pediatrician., To view the Multimedia ... Born of a need experienced by a parent with ...
... Care Abroad, CHICAGO, June 16 To ... medical care, new guiding,principles on medical tourism were ... policy-making meeting. The nine principles are,the first-of-its- kind, ... patients, employers, insurers and third-parties responsible for,coordinating travel ...
... is a precarious time, as about 15 percent of ... This risk increases when pregnant women undergo surgery, which ... York instituted a same-day pregnancy testing protocol. A study ... Analgesia shows that this protocol is effective in ...
... Will Expand Product Line and International ... ... PSS Systems, the leader,in legal holds and retention management solutions, announced ... existing,investors, including Lightspeed Venture Partners, Azure Capital, Granite,Ventures, and Cipio Partners, ...
... among diabetics , , MONDAY, June 16 (HealthDay News) -- ... diabetes, suggests a U.S. study. , "We found that ... diabetes than people without the disease. The hearing loss ... other factors such as exposure to loud noises, certain ...
... 16 Through emotional and,energetic performances, Garth Brooks, ... the Starkey Hearing Foundation, a world leader in,promoting ... its annual,"So the World May Hear" Awards Gala, ... Paul, Minn. With money raised at the Gala, ...
Cached Medicine News:Health News:Photo: Minding Your Child's Health: A Passport to Your Child's Well Being; A Ticket to Your Peace of Mind 2Health News:AMA Provides First Ever Guidance on Medical Tourism 2Health News:Same-day pregnancy test provides valuable guidance to pre-surgery patients 2Health News:PSS Systems Secures $18 Million in Financing 2Health News:PSS Systems Secures $18 Million in Financing 3Health News:PSS Systems Secures $18 Million in Financing 4Health News:Diabetes Might Help Spur Hearing Loss 2Health News:Garth Brooks, Jon McLaughlin, and Pat Benatar and Neil Giraldo Raise Their Voices to Help Starkey Hearing Foundation Raise More Than $5 Million at Annual Fundraiser 2
(Date:12/24/2014)... , Dec. 23, 2014  Lockton Dunning ... of Lockton Companies, announced the addition of Vice ... will join Lockton Dunning,s Pharmacy Consulting team, Excelsior ... of relevant industry experience to the position.  Most ... Market Sales at Diplomat Specialty Pharmacy, where she ...
(Date:12/24/2014)... 23, 2014 In response to urgent requests from the ... Sierra Leone , Direct Relief delivered two 10-bed ... the treatment of local health workers who contract Ebola while ... Ebola care center was constructed for foreign health care workers ... available for local Sierra Leonean health workers. With ...
(Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... AMSTERDAM, July 21, 2011 ,   ... diagnostics, announced today that, together with,thought-leading collaborators in ... the RATHER (Rational Therapy for,Breast Cancer) and COLTHERES ... receive nearly €12,million in funding from the European ...
... Quanterix Corporation, an in-vitro diagnostics (IVD) ... labs single molecule technology with unprecedented sensitivity ... of AccuPSA™, a fifth-generation digital immunoassay for ... 2-log improvement in sensitivity over today,s ultrasensitive ...
Cached Medicine Technology:Agendia Receives €1.27 Million in Funding from the EU's Seventh Framework Programme 2Agendia Receives €1.27 Million in Funding from the EU's Seventh Framework Programme 3Quanterix Digital Immunoassay for Prostate Specific Antigen Improves Analytical Performance 2
CleanBox DNA workstation with two 254nm UV lambs & 12-hr timer, 90cm (36-inch)width, single door, 115V (w/crating)...
... highthroughput reading of tube racks. Its camera-based vision ... one second per rack, making it ideal for ... the reader allows a rack to be read ... arms. An optical safety switch prevents a rack ...
... Polypropylene workbench top with powder-coated ... from 25"-34". Available in hundreds ... include shelves, drawers, light fixtures ... an expert in custom building ...
Perforated or Rod Top, Free Standing or Wall Mounted, Storage Cubby Optional, Polypropylene Construction...
Medicine Products: